JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Stryker Corp

Cerrado

SectorSanidad

360.47 0.16

Resumen

Variación precio

24h

Actual

Mínimo

356.48

Máximo

368.57

Métricas clave

By Trading Economics

Ingresos

-10M

849M

Ventas

1.1B

7.2B

P/B

Media del Sector

43.878

84.243

BPA

4.47

Rentabilidad por dividendo

0.92

Margen de beneficios

11.839

Empleados

53,000

EBITDA

351M

1.7B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+17.4% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.92%

2.28%

Próximas Ganancias

30 abr 2026

Fecha Próximo Dividendo

29 abr 2026

Próxima Fecha de Ex Dividendo

30 mar 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

4.3B

141B

Apertura anterior

360.31

Cierre anterior

360.47

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

54 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Stryker Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 ene 2026, 22:05 UTC

Ganancias

Stryker Logs Higher 4Q Profit On Sales Gains

30 oct 2025, 20:36 UTC

Ganancias

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31 jul 2025, 20:42 UTC

Ganancias

Stryker Lifts Guidance on Improving Tariff Outlook

1 may 2025, 20:56 UTC

Ganancias

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

30 ene 2026, 17:03 UTC

Charlas de Mercado

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 ene 2026, 21:07 UTC

Ganancias

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 ene 2026, 21:05 UTC

Ganancias

Stryker 4Q Adj EPS $4.47 >SYK

5 nov 2025, 19:38 UTC

Ganancias

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Ganancias

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 oct 2025, 20:21 UTC

Ganancias

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Adj EPS $3.19 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q EPS $2.22 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Sales $6.1B >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Net $859M >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Adj EPS $3.19 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Net $859M >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Sales $6.06B >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q EPS $2.22 >SYK

31 jul 2025, 20:09 UTC

Ganancias

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 jul 2025, 20:09 UTC

Ganancias

Stryker Sales >SYK

31 jul 2025, 20:09 UTC

Ganancias

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Sales $6B >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Net $884M >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q EPS $2.29 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Adj EPS $3.13 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Sales $6B >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q EPS $2.29 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q EPS $2.29 >SYK

Comparación entre iguales

Cambio de precio

Stryker Corp previsión

Precio Objetivo

By TipRanks

17.4% repunte

Estimación a 12 Meses

Media 432.21 USD  17.4%

Máximo 469 USD

Mínimo 387 USD

De acuerdo con 21 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stryker Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

21 ratings

18

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

373.92 / 383.99Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

54 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat